IP and Regulatory Rights in the Age of Personalized Medicine

Описание: To celebrate the launch of Evergreening Patent Exclusivity in Pharmaceutical Products (Hart, 2021) by Frantzeska Papadopoulou, on Tuesday 15 March 2022, the Institute for Intellectual Property and Market Law (IFIM) at Stockholm University hosted an online conference to discuss the current state and future of patent law and regulatory rights in the very exciting new field of personalized medicine.

Personalized medicine, referred to also as precision medicine, is a medical model separating patients into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient (or to the specific group) based on their predicted response or risk of disease. While personalized medicine seems to be an essential of modern healthcare, it is also rather unclear how innovations that are developed for its purposes align with patentability requirements and, in general, the way the patent system operates. Furthermore: how does the legal system of marketing authorization and other regulatory rights apply to personalized medicines? What needs to be done in order to provide a frictionless adaptation of the legal framework to new forms of healthcare?

These are some of the questions that were be discussed by a panel of prominent academics and practitioners working with these challenges in their respective roles.

***

The Speakers (in alphabetical order)

Duncan Matthews
Frantzeska Papadopoulou
Ulf Petrusson
Roberto Romandini
Hanna Tilus
Laura Valtere
Li Westerlund
Håkan Yildirim